Project Grant 2304404
Award Date
5/1/23
Completion Date
4/30/24
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Frisco, TX 75035, USA
Similar Awards
The National Institute of Child Health and Human Development (NICHD) awarded a $383,114 Small Business Innovation Research (SBIR) Phase I project grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Venova Technologies Inc., a women-led and minority-led medical device startup company. The grant funds the development of a novel, non-hormonal, long-acting female contraceptive device designed to address the critical unmet need for birth control options without hormonal...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $474,946 to develop a novel, non-hormonal, female-initiated contraceptive device. The research aims to create a dual-compartment vaginal device that enables women to self-administer a bioresponsive polymer fiber mat and a supplemental fluid to fortify natural contraceptive barriers at the...
This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I project aims to develop a novel, minimally invasive, bioabsorbable, steroid-eluting suture and surgical implant procedure to improve outcomes for 6 million patients suffering from rhinitis under the care of otolaryngologists. The $255,045 award, granted on September 15, 2023 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, will fund the formulation of dissolvable polymers,...
Biosapien Inc. received a $256,000 Project Grant award from the National Science Foundation on May 1, 2021 to develop a novel 3D printed biodegradable mesh delivering active pharmaceutical ingredients in a sustained and localized manner under the Small Business Innovation Research Phase I program. The SBIR Phase I grant supports the proof-of-concept stage of developing Biosapien's technology, with the work expected to be completed by June 30, 2022. The NSF Technology, Innovation, and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Novaurum Biosciences Incorporated supports the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The project aims to address the critical health and economic burden associated with implant-related infections by creating a biocompatible and antimicrobial coating to inhibit biofilm formation and protect against all types...
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Amphix Bio Inc. to develop scalable manufacturing methods for a novel supramolecular polymer-based spinal implant. The project aims to enable safer, simpler, and lower-cost spinal fusion surgery by advancing this regenerative medicine technology. The key deliverables include scaling up the production of the...
This $1,670,110 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development of a novel, multi-compartment intravaginal ring (IVR) for the prevention of genital herpes (HSV) and unintended pregnancy. The key products and services funded under this award include: Evaluating a panel of small-molecule inhibitors of soluble adenylyl cyclase (SAC) to select a lead...
This $1,016,000 Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a localized, sustained-release drug delivery platform for treating post-traumatic orthopedic injuries. The project, led by Nostopharma LLC, a woman-owned small disadvantaged business, aims to create a biodegradable nanoparticle formulation containing anti-inflammatory and Hedgehog pathway inhibitor drugs....
This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II Cooperative Agreement award of $1,000,000 to Biosens8, Inc. is developing a novel progesterone biosensor to improve at-home fertility monitoring. The project aims to translate optical sensing technology onto low-cost paper test strips and develop a portable device to measure progesterone from clinical blood samples. This will provide a quantitative, affordable, and accessible solution for the 7.7 million...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $291,440 to Contraline, Inc. to support the development of ADAM AIR, a non-hormonal, vas-occlusive contraceptive device. The key products to be delivered through this funding are advancements to Contraline's existing ADAM contraceptive hydrogel technology. Specifically, the project aims to develop a...